Rotstein Z, Mandelzweig L, Lavi B, Eldar M, Gottlieb S, Hod H
Department of Medical Management, Sheba Medical Center, Tel Hashomer, Israel.
Eur Heart J. 1999 Jun;20(11):813-8. doi: 10.1053/euhj.1998.1452.
The purpose of our study was to examine and compare the prognosis of acute myocardial infarction patients hospitalized in an intensive coronary care unit and in an internal medicine ward, in the era of reperfusion therapy, and to identify factors associated with the observed outcomes.
Patients hospitalized for acute myocardial infarction during the period 1994-1997 at the Sheba Medical Center, Tel Hashomer, Israel (n=2114), were grouped according to the hospital department in which they were treated: the intensive coronary care unit (n=1443, 68.3%) or an internal medicine ward (n=671, 31.7%). Baseline characteristics, comorbidity, hospital course, use of procedures and 30-day mortality were compared between the groups. Stepwise logistic regression was used to identify the factors associated with 30-day mortality. Crude 30-day mortality rates were 5.4% among all patients hospitalized in the intensive coronary care unit compared with 15.9% for all patients in an internal medicine ward (P<0.001); in a subgroup of patients aged 70 years and above these rates were 11.0% and 21.0%, respectively (P<0. 001). Among the independent predictors of the 30-day mortality identified in multivariate analysis was treatment only in an internal medicine ward (odds ratio: 1.48; 95% confidence interval: 1. 00-2.18). Reperfusion therapy was independently associated with a 53% reduction in 30-day mortality.
Our findings emphasize the importance of the treatment of acute myocardial infarction in the setting of intensive coronary care units in the thrombolytic era, in order to ensure early access to advanced diagnostic and therapeutic options for all patients, including the elderly.
我们研究的目的是在再灌注治疗时代,检查并比较在冠心病重症监护病房和内科病房住院的急性心肌梗死患者的预后,并确定与观察到的结果相关的因素。
1994年至1997年期间在以色列特拉维夫哈绍默的谢巴医疗中心因急性心肌梗死住院的患者(n = 2114),根据其接受治疗的医院科室进行分组:冠心病重症监护病房(n = 1443,68.3%)或内科病房(n = 671,31.7%)。比较两组之间的基线特征、合并症、住院过程、操作使用情况和30天死亡率。采用逐步逻辑回归确定与30天死亡率相关的因素。在冠心病重症监护病房住院的所有患者中,30天粗死亡率为5.4%,而在内科病房的所有患者中为15.9%(P<0.001);在70岁及以上的患者亚组中,这些比率分别为11.0%和21.0%(P<0.001)。在多变量分析中确定的30天死亡率的独立预测因素中,仅在内科病房接受治疗(优势比:1.48;95%置信区间:1.00 - 2.18)。再灌注治疗与30天死亡率降低53%独立相关。
我们的研究结果强调了在溶栓时代于冠心病重症监护病房环境中治疗急性心肌梗死的重要性,以便确保所有患者,包括老年人,都能尽早获得先进的诊断和治疗选择。